Locarnini SA - Search Results

1

The evolution and clinical impact of hepatitis B virus genome diversity.

Revill PA, Tu T, Netter HJ, Yuen LKW, Locarnini SA, Littlejohn M. Revill PA, et al. Among authors: locarnini sa. Nat Rev Gastroenterol Hepatol. 2020 Oct;17(10):618-634. doi: 10.1038/s41575-020-0296-6. Epub 2020 May 28. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32467580 Review.

2

Evolving therapies for the treatment of chronic hepatitis B virus infection.

Delaney W 4th, Bartholomeusz A, Locarnini SA. Delaney W 4th, et al. Among authors: locarnini sa. Expert Opin Investig Drugs. 2002 Feb;11(2):169-87. doi: 10.1517/13543784.11.2.169. Expert Opin Investig Drugs. 2002. PMID: 11829711 Review.

3

Advances in hepatitis C: what is coming in the next 5 years?

Locarnini SA, Bartholomeusz A. Locarnini SA, et al. J Gastroenterol Hepatol. 2002 Apr;17(4):442-7. doi: 10.1046/j.1440-1746.2002.02768.x. J Gastroenterol Hepatol. 2002. PMID: 11982725 Review.

4

Clinical relevance of viral dynamics and genotypes in hepatitis B virus.

Locarnini SA. Locarnini SA. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S322-8. doi: 10.1046/j.1440-1746.17.s3.21.x. J Gastroenterol Hepatol. 2002. PMID: 12472957 Review.

5

Mechanisms of drug resistance and novel approaches to therapy for chronic hepatitis C.

Locarnini SA. Locarnini SA. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S351-9. doi: 10.1046/j.1440-1746.17.s3.27.x. J Gastroenterol Hepatol. 2002. PMID: 12472963 Review.

6

Emerging therapies of hepatitis B and C.

Chen RY, Desmond PV, Locarnini SA. Chen RY, et al. Among authors: locarnini sa. J Gastroenterol Hepatol. 2002 Dec;17 Suppl:S471-81. doi: 10.1046/j.1440-1746.17.s4.13.x. J Gastroenterol Hepatol. 2002. PMID: 12534781 Review. No abstract available.

7

Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus.

Chen RY, Bowden S, Desmond PV, Dean J, Locarnini SA. Chen RY, et al. Among authors: locarnini sa. J Gastroenterol Hepatol. 2003 Jun;18(6):630-7. doi: 10.1046/j.1440-1746.2003.03019.x. J Gastroenterol Hepatol. 2003. PMID: 12753143

8

Antiviral drug resistance: clinical consequences and molecular aspects.

Bartholomeusz A, Locarnini SA. Bartholomeusz A, et al. Among authors: locarnini sa. Semin Liver Dis. 2006 May;26(2):162-70. doi: 10.1055/s-2006-939758. Semin Liver Dis. 2006. PMID: 16673294 Review.

9

SeqHepB: a sequence analysis program and relational database system for chronic hepatitis B.

Yuen LK, Ayres A, Littlejohn M, Colledge D, Edgely A, Maskill WJ, Locarnini SA, Bartholomeusz A. Yuen LK, et al. Among authors: locarnini sa. Antiviral Res. 2007 Jul;75(1):64-74. doi: 10.1016/j.antiviral.2006.11.014. Epub 2006 Dec 22. Antiviral Res. 2007. PMID: 17215050

10

Lamivudine resistance in patients with chronic hepatitis B: role of clinical and virological factors.

Thompson AJ, Ayres A, Yuen L, Bartholomeusz A, Bowden DS, Iser DM, Chen RY, Demediuk B, Shaw G, Bell SJ, Watson KJ, Locarnini SA, Desmond PV. Thompson AJ, et al. Among authors: locarnini sa. J Gastroenterol Hepatol. 2007 Jul;22(7):1078-85. doi: 10.1111/j.1440-1746.2006.04630.x. J Gastroenterol Hepatol. 2007. PMID: 17608854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page